Publicacións (21) Publicacións nas que participase algún/ha investigador/a

2007

  1. Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons

    Neurobiology of Aging, Vol. 28, Núm. 4, pp. 555-567

  2. Biocompatibility of agarose gel as a dermal filler: Histologic evaluation of subcutaneous implants

    Plastic and Reconstructive Surgery, Vol. 120, Núm. 5, pp. 1161-1169

  3. Botulinum toxin A for treating muscular contractures in cephalic tetanus

    British Journal of Oral and Maxillofacial Surgery, Vol. 45, Núm. 7, pp. 573-575

  4. Cálculo del SAR en el cerebro de animales pequeños expuestos a la radiación de un sistema experimental GSM: efectos biológicos

    URSI 2007 XXII Simposium Nacional de la Unión Internacional de Radio

  5. Development of the serotonergic system in the central nervous system of the sea lamprey

    Journal of Chemical Neuroanatomy, Vol. 34, Núm. 1-2, pp. 29-46

  6. Effects of GABA and GABA receptor inhibition on differentiation of mesencephalic precursors into dopaminergic neurons in vitro

    Developmental Neurobiology, Vol. 67, Núm. 12, pp. 1549-1559

  7. Estradiol sustained release from high affinity cyclodextrin hydrogels

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 66, Núm. 1, pp. 55-62

  8. Experimental setup for radiation of small animals

    Proceedings of the 9th European Conference on Wireless Technology, ECWT 2006

  9. Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism

    Journal of Endocrinological Investigation, Vol. 30, Núm. 6, pp. 470-476

  10. Mechanism of 6-hydroxydopamine neurotoxicity: The role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons

    Journal of Neurochemistry, Vol. 103, Núm. 1, pp. 145-156

  11. Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft

    Brain, Vol. 130, Núm. 5, pp. 1306-1316

  12. Oral health status in patients with moderate-severe and terminal renal failure

    Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 12, Núm. 4, pp. 8

  13. Oral health status in patients with moderate-severe and terminal renal failure.

    Medicina oral, patología oral y cirugía bucal, Vol. 12, Núm. 4

  14. Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma

    Oral Diseases, Vol. 13, Núm. 3, pp. 285-290

  15. Placas de chagrin

    Anales de Pediatria

  16. Serotonin decreases generation of dopaminergic neurons from mesencephalic precursors via serotonin type 7 and type 4 receptors

    Developmental Neurobiology, Vol. 67, Núm. 1, pp. 10-22

  17. Sertaconazole-HPβCD-pluronic F127 solid inclusion complexes: Characterization and effect on drug solubility

    Journal of Inclusion Phenomena and Macrocyclic Chemistry

  18. The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP

    Synapse, Vol. 61, Núm. 12, pp. 1006-1012

  19. Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson's disease

    Neurochemical Research, Vol. 32, Núm. 1, pp. 99-105

  20. Varón de 70 años con lesiones ulceradas en la pared torácica

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 10, pp. 651-652